Reneo Pharmaceuticals News

Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Target

TipRanksMar 31 10:35 ET

Reneo Pharmaceuticals GAAP EPS of -$2.52

Seeking AlphaMar 28 15:13 ET

Reneo Pharmaceuticals: Q4 Earnings Insights

Reneo Pharmaceuticals (NASDAQ:RPHM) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:35 AM.Here's what investors need to know about the announcement.EarningsReneo Pharmaceuticals mis

BenzingaMar 28 08:00 ET

Express News | Reneo Pharmaceuticals Q4 GAAP EPS $(0.70) Misses $(0.62) Estimate; Cash, Cash Equivalents, And Short-term Investments Of $103M

Moomoo 24/7Mar 28 07:37 ET

Press Release: Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a

Dow JonesMar 28 07:35 ET

Reneo Pharmaceuticals 4Q Loss/Shr 70c >RPHM

Reneo Pharmaceuticals 4Q Loss/Shr 70c >RPHM

Dow JonesMar 28 07:35 ET

Reneo Pharmaceuticals Announces Workforce Reduction Costs

TipRanksFeb 24 09:56 ET

Reneo Pharmaceuticals to Cut 20% of Workforce in Second Round of Layoffs

By Ben Glickman Reneo Pharmaceuticals plans to cut more jobs, about 20% of its workforce, months after laying off the majority of its staff. The Irvine, Calif.-based company announced a 70% headcoun

WSJFeb 23 16:53 ET

Express News | Reneo Pharmaceuticals Shares Are Trading Higher After Concentra Sent an Acquisition Proposal to Acquire 100% of Equity of the Company for $1.80 per Share

Moomoo 24/7Dec 27, 2023 09:29 ET

Cytokinetics, Burford Capital, Cipher Mining Among Premarket Gainers' Pack

Seeking AlphaDec 27, 2023 08:27 ET

Reneo Pharmaceuticals Inc Says On Dec 26, Concentra, An Affiliate Of Tang Capital Partners, Sent Acquisition Proposal To The Co; On Behalf Of Concentra Biosciences, Submit Non-Binding Proposal To Acquire 100% Of Equity Of Reneo For $1.80 Per Share

Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmaceuticals, Inc.c/o Gregory J. Flesher, President and Chief Executive Offic

BenzingaDec 26, 2023 17:09 ET

Analysts Offer Insights on Healthcare Companies: Rain Therapeutics (RAIN), Reneo Pharmaceuticals (RPHM) and Bicycle Therapeutics (BCYC)

TipRanksDec 19, 2023 02:42 ET

Ladenburg Thalmann Downgrades Reneo Pharmaceuticals to Neutral From Buy

Reneo Pharmaceuticals (RPHM) has an average rating of hold and price targets ranging from $1 to $33.81, according to analysts polled by Capital IQ. Price: 1.36, Change: +0.02, Percent Change: +1.49

MT NewswiresDec 15, 2023 08:08 ET

Reneo Pharmaceuticals Price Target Cut to $1.50/Share From $30.00 by HC Wainwright & Co.

Reneo Pharmaceuticals Price Target Cut to $1.50/Share From $30.00 by HC Wainwright & Co.

Dow JonesDec 15, 2023 06:40 ET

Reneo Pharmaceuticals Cut to Hold From Buy by Jefferies

Reneo Pharmaceuticals Cut to Hold From Buy by Jefferies

Dow JonesDec 15, 2023 06:00 ET

Leerink Partners Downgrades Reneo Pharmaceuticals to Market Perform, Announces $1 Price Target

Leerink Partners analyst Joseph Schwartz downgrades Reneo Pharmaceuticals from Outperform to Market Perform and announces $1 price target.

Analyst UpgradesDec 15, 2023 04:54 ET

Reneo Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/15/2023 -27.01% Leerink Partners → $1 Downgrades Outperform → Market Perform 11/15/2023 — William Blair

BenzingaDec 15, 2023 04:53 ET

Hold Rating and Lowered Price Target for Reneo Pharmaceuticals Following STRIDE Study Setback and Operational Challenges

TipRanksDec 15, 2023 04:46 ET

U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.43%

InvestingDec 14, 2023 16:30 ET

Reneo Pharmaceuticals RPHM Pivotal Trial Fail; Codexis CDXS Deal

BioPharmCatalystDec 14, 2023 15:26 ET